[ad_1]
The Minister of National Defense, Nicolae Ciucă, announced that the Cantacuzino Institute will launch an immunomodulatory drug developed by its own researchers at the end of the year. It is a food supplement with biostimulant and antioxidant properties, which increases the body’s resistance to infections.
“I spoke with the director of the Cantacuzino Institute, Coronel Oancea, in the last period of time he focused a lot on what it means to increase the testing capacity. It is also working on an immunomodulatory drug, which will soon be on the market, and has taken steps to get the old trivalent vaccine production line back on track and begin testing so that, as proposed at the institute level, from the next year, to be able to produce the vaccine. The immunomodulatory drug will go on sale at the end of the year ”, showed Nicolae Ciucă.
Specialists from the “Cantacuzino” National Institute for Medical-Military Research-Development have developed a new immunomodulatory product, which has properties to stimulate immunity, causing a greater resistance of the organism to infections.
Publisher: BP
